High expression of Toll-like receptor 5 correlates with better prognosis in non-small-cell lung cancer: an anti-tumor effect of TLR5 signaling in non-small cell lung cancer

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Cancer Research and Clinical Oncology

• Publication date

  2014-02-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00432-014-1616-4PMID 24549739PMCID PMC11824051
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Toll-like receptor 5 and the emerging role of bacteria in carcinogenesis

  2013influential reference
• Toll-like receptor 5 (TLR5) expression is a novel predictive marker for recurrence and survival in squamous cell carcinoma of the tongue

  2013influential reference
• Nanog, a novel prognostic marker for lung cancer.

  2013cited by this paper
• Genetics and biomarkers in personalisation of lung cancer treatment.

  2013cited by this paper
• BCL11A overexpression predicts survival and relapse in non-small cell lung cancer and is modulated by microRNA-30a and gene amplification

  2013cited by this paper
• Toll-like receptor 5 agonism protects mice from radiation pneumonitis and pulmonary fibrosis.

  2012influential reference
• Anti-Proliferative Effect of Cytohesin Inhibition in Gefitinib-Resistant Lung Cancer Cells

  2012cited by this paper
• Expression profiles of Toll-like receptors in non-small cell lung cancer and idiopathic pulmonary fibrosis.

  2012cited by this paper
• Increased Expression of Toll-like Receptors (TLR) 2, 4 and 5 in Gastric Dysplasia

  2011cited by this paper
• Lung cancer and Toll-like receptors

  2011cited by this paper
• Delays in the diagnosis of lung cancer.

  2011cited by this paper
• Establishment and characterization of primary lung cancer cell lines from Chinese population

  2011cited by this paper
• Inhibited proliferation of human lung fibroblasts by LPS is through IL-6 and IL-8 release.

  2011cited by this paper
• Activation of Toll-like receptor 5 on breast cancer cells by flagellin suppresses cell proliferation and tumor growth.

  2011cited by this paper
• Pattern recognition receptors and inflammation.

  2010cited by this paper
• Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance.

  2010cited by this paper
• The IASLC Lung Cancer Staging Project: A Proposal for a New International Lymph Node Map in the Forthcoming Seventh Edition of the TNM Classification for Lung Cancer

  2009cited by this paper
• Toll-like receptors and cancer

  2009cited by this paper
• Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis.

  2009influential reference
• Surgeon specialty and long-term survival after pulmonary resection for lung cancer.

  2009cited by this paper
• Toll-like receptors in the respiratory system: Their roles in inflammation

  2008cited by this paper
• Combined immunogene therapy of IL-6 and IL-15 enhances anti-tumor activity through augmented NK cytotoxicity.

  2008cited by this paper
• Toll-like receptor 5 engagement modulates tumor development and growth in a mouse xenograft model of human colon cancer.

  2008influential reference
• Cancer Statistics, 2007

  2007cited by this paper
• Interleukin‐6 is a potent growth factor for ER‐α‐positive human breast cancer

  2007cited by this paper
• Increased expression of Toll-like receptor 5 during progression of cervical neoplasia

  2007cited by this paper
• Interleukin-6 is a potent growth factor for ER-alpha-positive human breast cancer.

  2007cited by this paper
• Clonogenic assay of cells in vitro

  2006cited by this paper
• Tumor-derived interleukin (IL)-6 induced anti-tumor effect in immune-compromised hosts

  2005cited by this paper
• Tumor-derived interleukin (IL)-6 induced anti-tumor effect in immune-compromised hosts

  2005cited by this paper
• Toll-like receptor signalling

  2004cited by this paper
• Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancer

  2004cited by this paper
• [Delays in the diagnosis of lung cancer].

  2003cited by this paper
• A Toll-like receptor recognizes bacterial DNA

  2003cited by this paper
• Lung cancer--time to move on from chemotherapy.

  2002cited by this paper
• Toll-like receptors and their ligands.

  2002cited by this paper
• Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.

  2001cited by this paper
• The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5

  2001cited by this paper
• A Toll-like receptor recognizes bacterial DNA

  2000cited by this paper
• Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

  1998cited by this paper

• Clinical significance and biological function of interferon regulatory factor 1 in non-small cell lung cancer

  2024cites this paper
• Toll-like Receptors: Key Players in Squamous Cell Carcinoma Progression

  2024cites this paper
• Identification of TLRs as potential prognostic biomarkers for lung adenocarcinoma

  2023cites this paper
• Toll-like receptor-targeted nanoparticles: A powerful combination for tumor immunotherapy

  2023cites this paper
• Microbial-Derived Toll-like Receptor Agonism in Cancer Treatment and Progression

  2022cites this paper
• TLR4 regulatory region variants reduce the susceptibility of small-cell lung cancer in Chinese population

  2022cites this paper
• Understanding the role of Toll-like receptors in lung cancer immunity and immunotherapy

  2022cites this paper
• De- “bug”-ing the microbiome in lung cancer

  2022cites this paper
• Reverse Vaccinology Approach in Constructing a Multi-Epitope Vaccine Against Cancer-Testis Antigens Expressed in Non-Small Cell Lung Cancer

  2021cites this paper
• A highly expressed mRNA signature for predicting survival in patients with stage I/II non-small-cell lung cancer after operation

  2021cites this paper
• A highly expressed mRNA signature for predicting survival in patients with stage I/II non-small-cell lung cancer after operation

  2021cites this paper
• Role of Toll-Like Receptors in Molecular and Cellular Mechanisms of Respiratory Diseases

  2021cites this paper
• Immunohistochemical Analysis of Toll-Like Receptors, MyD88, and TRIF in Human Papillary Thyroid Carcinoma and Anaplastic Thyroid Carcinoma

  2021cites this paper
• SFTPA1 is a potential prognostic biomarker correlated with immune cell infiltration and response to immunotherapy in lung adenocarcinoma

  2021cites this paper
• High Tissue TLR5 Expression Predicts Better Outcomes in Colorectal Cancer Patients

  2021cites this paper
• A narrative review of tumor-associated macrophages in lung cancer: regulation of macrophage polarization and therapeutic implications

  2021cites this paper
• Impact of Genetic Variation in TLR4 3′UTR on NSCLC Genetic Susceptibility

  2020cites this paper
• Toll-like receptor-induced cytokines as immunotherapeutic targets in cancers and autoimmune diseases.

  2020cites this paper
• Toll-like Receptors from the Perspective of Cancer Treatment

  2020cites this paper
• Elevated TLR5 expression in vivo and loss of NF-κΒ activation via TLR5 in vitro detected in HPV-negative oropharyngeal squamous cell carcinoma.

  2020cites this paper
• In HPV-negative oropharyngeal squamous cell carcinoma, elevated toll-like receptor 2 immunoexpression may increase the risk of disease-specific mortality.

  2020cites this paper
• In Silico Approach in Designing a Novel Multi-Epitope Vaccine Candidate against Non-Small Cell Lung Cancer with Overexpressed G Protein-Coupled Receptor 56

  2020cites this paper
• TLR5: A prognostic and monitoring indicator for triple-negative breast cancer

  2019cites this paper
• TLR5 is a new reporter for triple‐negative breast cancer indicated by radioimmunoimaging and fluorescent staining

  2019cites this paper
• Evaluation of prognostic markers for oropharyngeal carcinoma using tissue microarray

  2019cites this paper
• The prognostic value of toll-like receptor5 and programmed cell death-ligand1 in patients with peripheral T-cell non-Hodgkin lymphoma

  2019cites this paper
• NLRP3 promotes tumor growth and metastasis in human oral squamous cell carcinoma

  2018cites this paper
• Rôle de TLR7 dans la progression tumorale dans le cancer du poumon

  2017influential citation
• Roles of toll-like receptors: From inflammation to lung cancer progression

  2017influential citation
• Toll-like receptor stimulation in cancer: A pro- and anti-tumor double-edged sword.

  2017cites this paper
• Toll-like receptor expression in human non-small cell lung carcinoma: potential prognostic indicators of disease

  2017cites this paper
• The influence of the commensal microbiota on distal tumor-promoting inflammation.

  2017cites this paper
• Toll-like receptor 5 and 7 expression may impact prognosis of HPV-positive oropharyngeal squamous cell carcinoma patients

  2017cites this paper
• Recent Findings on the Application of Toll-like Receptors Agonists in Cancer Therapy.

  2017cites this paper
• Identification of novel genes that regulate androgen receptor signaling and growth of androgen-deprived prostate cancer cells

  2015influential citation
• p53 amplifies Toll-like receptor 5 response in human primary and cancer cells through interaction with multiple signal transduction pathways

  2015cites this paper
• ADAM15 targets MMP9 activity to promote lung cancer cell invasion.

  2015cites this paper
• ADAM 15 targets MMP 9 activity to promote lung cancer cell invasion

  year unknowncites this paper